You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

5 May 2021

COVID-19 vaccine batch release information is now available.

23 April 2021
Three additional Australian cases of TTS likely linked to vaccine
16 April 2021
Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine
14 April 2021
The granting of a provisional determination means that the TGA has made a decision that GSK is now eligible to apply for provisional registration for the treatment in the Australian Register of Therapeutic Goods.
9 April 2021
Updated safety advisory – rare and unusual blood clotting syndrome (thrombosis with thrombocytopaenia)
8 April 2021
Updated storage conditions for the Pfizer COVID-19 vaccine
29 March 2021
It is alleged the company breached the Therapeutic Goods Act 1989 in relation to the importation of surgical face masks.
26 March 2021
The TGA has granted provisional approval to Pfizer Australia Pty Ltd for its COVID-19 vaccine, COMIRNATY, making it the first COVID-19 vaccine to receive regulatory approval in Australia.
23 March 2021
The Melbourne-manufactured AstraZeneca vaccine is now available for Australians, with the TGA this evening approving the release of the first four batches.
21 March 2021
TGA has approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia.


Further information

Contact TGA Info

Tel: 1800 020 653

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us